Zheng Lei, Baumann Ulrich, Reymond Jean-Louis
Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland.
J Biochem. 2003 May;133(5):577-81. doi: 10.1093/jb/mvg074.
Functional expression of catalytic antibodies in the cytoplasm of E. coli is potentially of great interest in searching for new catalysts by genetic selection. Herein, a catalytic antibody single chain Fv (ScFv) 14D9, which catalyzes a highly enantioselective protonation, was expressed as a NusA fusion protein under the T7 promoter. A functional disulfide-containing ScFv fusion protein was obtained in the oxidizing environment of bacterial cytoplasm. The 14D9 ScFv could not be overexpressed alone without NusA fusion. The highly soluble NusA protein most likely retards aggregate formation of ScFv and indirectly supports correct folding and disulfide bridge formation in the fusion construct ScFv-NusA. The ScFv-NusA fusion product shows highly enantioselective, specific, hapten inhibited catalytic activity comparable to its parent monoclonal antibody, 14D9. The NusA fusion method might be generally helpful for functional antibody expression in vivo and for the new development of biocatalysts by genetic selection.
通过基因筛选寻找新型催化剂时,在大肠杆菌细胞质中催化抗体的功能性表达可能具有重大意义。在此,一种催化高度对映选择性质子化的催化抗体单链Fv(ScFv)14D9,在T7启动子下表达为NusA融合蛋白。在细菌细胞质的氧化环境中获得了一种含功能性二硫键的ScFv融合蛋白。若无NusA融合,14D9 ScFv无法单独过量表达。高度可溶的NusA蛋白极有可能延缓ScFv的聚集体形成,并间接支持融合构建体ScFv-NusA中正确的折叠和二硫键形成。ScFv-NusA融合产物表现出高度对映选择性、特异性、半抗原抑制的催化活性,与其亲本单克隆抗体14D9相当。NusA融合方法可能普遍有助于体内功能性抗体的表达以及通过基因筛选实现生物催化剂的新发展。